PubMed:26269599 / 700-1039 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/26269599","sourcedb":"PubMed","sourceid":"26269599","source_url":"http://www.ncbi.nlm.nih.gov/pubmed/26269599","text":"We expressed, purified, and characterized A. fumigatus CYP51B, including determination of its substrate preferences, catalytic parameters, inhibition, and x-ray structure in complexes with voriconazole and the experimental inhibitor (R)-N-(1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl)-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide (VNI).","tracks":[{"project":"sentences","denotations":[{"id":"T6","span":{"begin":0,"end":339},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T6","pred":"source","obj":"sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"sentences","color":"#cd93ec","default":true}]}]}}